5
Years Operating
2021 – 2025
$800K
Deployed to Research
5-yr cumulative
6
Countries Funded
Active grantees
$500K
Break Through Cancer
Defying Osteosarcoma TeamLab
2
White House Moonshot
2025 invitations
Capital Deployed · 2021–2025
USA
NORWAY
UK
AUSTRIA
ITALY
VENEZUELA
Break Through Cancer · Defying Osteosarcoma TeamLab
Multi-institution US osteosarcoma research consortium · named partner
$500K
Oslo University Hospital · Radiumhospitalet
Pediatric oncology research partnerships · Norway
Active
Direct grants to Principal Investigators · Europe and Latin America
Capital routed directly to researchers · no intermediary tax
4 countries
Institutional Credibility
White House Cancer Moonshot · 2025
Two invitations to working sessions shaping US federal pediatric oncology research priorities.
Break Through Cancer · Named Partner
$500K committed to the Defying Osteosarcoma TeamLab · a flagship multi-institution US research consortium.
Financial Transparency
Candid Platinum Seal · the highest transparency tier · all financial and operational data publicly disclosed.
Operating Model
Lean operating structure · 20+ years institutional finance experience at the helm · grant capital flows directly to researchers without a fundraising overhead layer.
Active in 2026
Defying Osteosarcoma TeamLab
$500K commitment to Break Through Cancer · 2025–2028 multi-year deployment · ongoing engagement with the flagship US osteosarcoma research consortium.
Radiumhospitalet Training Room
Dedicated oncology patient training facility at Oslo's new Radiumhospitalet · partnership with Oslo University Hospital · 2026 build.
Holmenkollstafetten · Four-Peat
Bardo Running Club · new charity-category record at Holmenkollstafetten each year 2023 · 2024 · 2025 · 2026 · four-peat secured 9 May 2026 · 100+ runners active across the club.